Janssen prima facie in contempt of STELARA injunction 01 Oct 2014AItken Klee LLP After finding that Janssen’s STELARA products infringed AbbVie’s (formerly Abbott) Canadian Patent No. 2,365,281 (see here), Justice Hughes subsequently granted a permanent... Read More